This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Ucb Pharma Gmbh. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovations by Cara Heers in Hyperexcitability Disorders
Introduction
Cara Heers is an accomplished inventor based in Monheim, Germany. She has made significant contributions to the field of medical science, particularly in the treatment of hyperexcitability disorders. Her innovative approach focuses on the use of peptide compounds to address various health issues.
Latest Patents
Cara Heers holds a patent for her invention titled "Therapy for Hyperexcitability Disorders." This patent is directed towards the use of a class of peptide compounds for treating diseases associated with hyperexcitability. Additionally, her invention addresses the dysfunction of ion channels, providing a novel therapeutic avenue for affected patients. She has 1 patent to her name.
Career Highlights
Cara is currently employed at UCB Pharma GmbH, where she continues to work on groundbreaking research and development in the pharmaceutical industry. Her expertise and dedication have positioned her as a valuable asset in her field.
Collaborations
Throughout her career, Cara has collaborated with notable colleagues, including Thomas Stoehr and Bettina Beyreuther. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Cara Heers exemplifies the spirit of innovation in the medical field, particularly through her work on hyperexcitability disorders. Her contributions are paving the way for new treatments that can significantly improve patient outcomes.